Bactoshield CHG
- Product NDC
- 11084-039
- 11-digit product format
- 110840039
- Labeler code
- 11084
- Product ID
- 11084-039_70a1fe5a-1fd9-4350-9bea-119bd3599ee8
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- CHLORHEXIDINE GLUCONATE
- Dosage form
- SOLUTION
- Route
- TOPICAL
- Labeler
- SC Johnson Professional USA, Inc.
- Application
- NDA019125
- Marketing category
- NDA
- Marketing start
- 2022-12-01
- Marketing end
- 2027-12-31
- Substance
- CHLORHEXIDINE GLUCONATE
- Active strength
- 40 mg/mL
- Pharmacologic classes
- Decreased Cell Wall Integrity [PE]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bactoshield CHG
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CHLORHEXIDINE GLUCONATE | 40 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | MOR84MUD8E |
| Rxcui | 211365, 2186092 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 11084-039-03 | Bactoshield CHG | 118 mL in 1 BOTTLE | SOLUTION | 118 | | 2 |
| 11084-039-24 | Bactoshield CHG | 946 mL in 1 BOTTLE | SOLUTION | 946 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 11084-039 | BACTOSHIELD CHG (CHLORHEXIDINE GLUCONATE) SOLUTION [SC JOHNSON PROFESSIONAL USA, INC.] | 1 | Current NDC, Legacy NDC, 2 package rows | 20221202_4c133721-ad9a-4807-8ad5-c3efdff1ec52.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 11084-039-03 | 11084003903 | 118 mL in 1 BOTTLE (11084-039-03) | 118 ml | 2022-12-01 | 2027-12-31 | No | No | Current |
| 11084-039-24 | 11084003924 | 946 mL in 1 BOTTLE (11084-039-24) | 946 ml | 2022-12-01 | 2027-12-31 | No | No | Current |